Symptom Management II

Learning Objectives

1. Explain the definitions of nausea and vomiting and the pathophysiology of CINV

2. Review the mechanism of actin, adverse effects, and dosing of the agents used for CINV prevention and treatment

3. Explore the guideline recommendations for CINV prevention

4. Identify most common risk factors for the development of mucositis and review current treatment recommendations

5. Review mechanism, symptoms and treatment options for chemotherapy-induced constipation and diarrhea

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
05/18/2021
Registration Expires: 
01/15/2023
Part of: 
DCI Advanced Practice Provider Webinar Lecture Series
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.